Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Microbes Infect. 2020 Aug 3;22(10):540–549. doi: 10.1016/j.micinf.2020.07.006

Table 2.

Strain characteristics of S. aureus strains isolated from pediatric persistent carriers.

Pediatric Persistent Carrier* Antibiotic Resistance of Carriage Isolate(s) Ridom spa Type 1st Nasal Swab Ridom spa Type 2nd Nasal Swab Ridom spa Type 3rd Nasal Swab
P1 MSSA t1077/ t1077 t1077/ t1077 t1077/ t1077
P2 MSSA New32/New32** New32/New32 NEG¥/t008
P3 MSSA NEG/t9964 NEG/t9964 t9964/t9964
P4 MSSA NEG/t13031 t13031/t13031 t13031/t13031
P5 MSSA t338/t338 t338/t338 t338/t338
P6 Both MSSA t002/t002 t620/NEG t620/t620
PC7 MSSA t164/t164 t164/t164 t164/t164
PC8 MSSA t164/t164 t164/t164 t164/t164
PC9 MSSA t165/t165 t165/t165 t165/t165
PC10 MRSA§ and MSSA, respectively t008/t008 t008/t008 NEG/t1978
PC11 MRSA t1978/t1978 t1978/t1978 t1978/t1978
PC12 MRSA t008/t008 t008/t008 t008/NEG
*

Persistent carriage is defined by the identification of S. aureus at each sampling time point.

At each sampling time point swabs were used to inoculate MSA plates. The swab tips were cultured in TSB for 48 h and then used to inoculate a second MSA plates. Therefore, for each collection time point, an individual could have two S. aureus colonies available for analysis. S. aureus spa type in bold designates the spa type identified at the time of the last nasal sampling and also the isolate used to stimulate respective persistent carriers and in the generation of the Carrier Mix.

MSSA, methicillin susceptible S. aureus

**

This provisional new spa type with the following repeats: r07-r23-r12-r21-r12-r17-r20-r17-r12-r12-r24

¥

NEG, S. aureus not detected.

§

MRSA, methicillin resistant S. aureus